How DeepDerm works
Real-time multimodal analysis integrated into your workflow
Clinician-first. Evidence-driven. Built for better skin outcomes.
Skin Biopsies performed yearly
Found benign
Annually in Australia alone
DeepDerm aims to reduce unnecessary biopsies and enable earlier, more accurate detection of melanoma — saving time, cost, and lives.
AI Intelligence
Real-time multimodal analysis at point-of-care.
Clinical Insight
Designed with dermatologists, validated in trials.
Equity in Access
Bringing early detection to every community.
Designed for Clinical Simplicity
- Seamless teledermatology integration
- No disruption to existing workflows
- Portable, non-invasive device
- Clinically interpretable results
- Real-time decision support
Our Impact
94% Accuracy
Validated in pilot trials
>1000 Images Analysed
Across real clinical settings
2 Clinical Partners
MoleMap & PeterMac
Our Vision
Building the next generation of AI-assisted skin care
Skin cancer remains Australia’s most diagnosed cancer — but DeepDerm is changing that. By combining advanced thermal and spectral imaging with AI, we empower clinicians to detect abnormalities invisible to the naked eye.
Featured Partners
Trusted by leading clinical institutions
Let’s transform skin health together.
Join our pilot or partner with us in clinical research.